Chemotherapy News and Research

Latest Chemotherapy News and Research

Sunitinib malate drug shows significant benefits over standard treatment for advanced kidney cancer

According to a new study, the drug sunitinib malate (Sutent.) is more effective than the current standard cytokine treatment given as an initial therapy for patients with advanced kidney cancer, also known as metastatic renal cell carcinoma (mRCC).

5 Jun 2006

Taxotere combined with standard chemotherapy improves survival in advanced head and neck cancers

The addition of docetaxel (Taxotere) to an initial chemotherapy regimen for inoperable head and neck cancers reduced mortality by nearly 30 percent over three years following treatment compared to the standard two-drug combination.

5 Jun 2006

HERA trial continues to demonstrate significant patient benefits from Herceptin

New 23-month follow-up data from HERA, one of the largest breast cancer trials ever carried out, show that Herceptin (trastuzumab) following standard chemotherapy significantly reduced the risk of death by 34% for women with early-stage HER2-positive breast cancer.

5 Jun 2006

Genes variations raise risk of heart disease after treatment for childhood cancer

Gene variations may raise the risk that survivors of childhood cancer will suffer congestive heart failure as a complication of drugs they received during cancer treatment.

5 Jun 2006

"Smart bomb" cancer therapy combo effective

Experts have more good news on the breast cancer front; they say they by using a combination of therapies it may be possible to extend the lives of thousands of women with advanced breast cancer.

4 Jun 2006

Scientists use "small interfering RNAs" to block the spread of human colorectal cancer cells

Using one of the newest and most powerful tools of biomedical science, University of Texas Medical Branch at Galveston (UTMB) researchers have scored a dramatic success in the battle against colorectal cancer.

1 Jun 2006

Molecular diagnostic test for early-stage breast cancer

Researchers at Montefiore Medical Center are leading a nationwide clinical trial to determine whether a new genetic test can be used to personalize treatment for early-stage breast cancer.

1 Jun 2006

Experimental treatment increases response rates in advanced lung cancer

An early phase study pairing an experimental targeted therapy with a common anti-inflammatory produced promising results in patients with advanced lung cancer, researchers at UCLA's Jonsson Cancer Center reported.

1 Jun 2006

EU ruling on breast drug Herceptin will end 'post code lottery' in Britain

The European Union has approved the use of the breast cancer drug Herceptin for use in patients with an early stage of the aggressive HER2-positive type of breast cancer.

24 May 2006

Role of partial nephrectomy in the treatment of upper tract transitional cell carcinoma

Traditionally, upper tract transitional cell carcinoma (TCC) is managed with nephroureterectomy with excision of a bladder cuff.

22 May 2006

OK from the FDA for synthetic marijuana drug

Despite saying quite recently that it does not support the use of marijuana for medical purposes, the U.S. Food and Drug Administration (FDA) has given marketing approval for a drug which is a synthetic version of the active ingredient in marijuana.

17 May 2006

First animal model that mimics human head and neck cancer

An Oregon Health & Science University Cancer Institute research laboratory has developed a novel mouse model designed specifically to study the often devastating head and neck squamous cell cancers.

16 May 2006

Gene amplification could guide treatment for high-risk breast cancer

A new study shows that breast cancer patients with an "amplification," or greater number of copies, of the TOP2A gene are 45% more likely than women who do not have this amplification to benefit from a longer course of anthracycline-based adjuvant chemotherapy.

11 May 2006

Promising chemo, therapeutic viruses, cutting-edge surgery debut at M. D. Anderson Cancer Center

Brain tumor specialists at The University of Texas M. D. Anderson Cancer Center are poised on the brink of a new era.

10 May 2006

Online infusion calculator and a computerized drug ordering system reduces medication errors in children

Two new studies from the Johns Hopkins Children's Center show that computerizing ordering of chemotherapy and other types of intravenous drug infusions for children greatly reduces the risk of potentially dangerous medical errors.

8 May 2006

Significant changes in tumor growth can be detected through short interval follow-up

These growths may have important clinical implications in the management of patients, enabling early discontinuation of potentially toxic chemotherapy drugs.

4 May 2006

Image-guided kidney biopsy can diagnose benign kidney tumors and has a low rate of complications

For the study, 407 image-guided kidney lesion biopsies were performed in 377 patients using either CT, ultrasound, or a combination of both to guide a small needle through the skin of the patient to take a sample of the lesion.

3 May 2006

Inhibiting cell process may give cancer drug a boost

A molecule that interferes with the internal scaffolding that shapes the cell may kill cancer cells, retard the growth of tumors and give a boost to a common chemotherapy drug, according to findings appearing in the May 3 issue of the European Journal of Cancer.

3 May 2006

Differential effects of HOXB4 on nonhuman primate short and long-term repopulating cells

Transplantation of hematopoietic stem cells (HSCs, the cells that can give rise to all blood and most immune cell types) can save patients whose own hematopoietic system is defective or has been destroyed (often through radiation or chemotherapy of cancer).

3 May 2006

MDCT urography shows potential for detecting bladder cancer without surgery

MDCT urography is a promising technique for detecting bladder tumors both with and without contrast material, helping patients avoid an invasive test, according to a new study by researchers from the University of Michigan Health System in Ann Arbor, MI.

3 May 2006

Chemotherapy News and Research

Latest Chemotherapy News and Research

Sunitinib malate drug shows significant benefits over standard treatment for advanced kidney cancer

Taxotere combined with standard chemotherapy improves survival in advanced head and neck cancers

HERA trial continues to demonstrate significant patient benefits from Herceptin

Genes variations raise risk of heart disease after treatment for childhood cancer

"Smart bomb" cancer therapy combo effective

Scientists use "small interfering RNAs" to block the spread of human colorectal cancer cells

Molecular diagnostic test for early-stage breast cancer

Experimental treatment increases response rates in advanced lung cancer

EU ruling on breast drug Herceptin will end 'post code lottery' in Britain

Role of partial nephrectomy in the treatment of upper tract transitional cell carcinoma

OK from the FDA for synthetic marijuana drug

First animal model that mimics human head and neck cancer

Gene amplification could guide treatment for high-risk breast cancer

Promising chemo, therapeutic viruses, cutting-edge surgery debut at M. D. Anderson Cancer Center

Online infusion calculator and a computerized drug ordering system reduces medication errors in children

Significant changes in tumor growth can be detected through short interval follow-up

Image-guided kidney biopsy can diagnose benign kidney tumors and has a low rate of complications

Inhibiting cell process may give cancer drug a boost

Differential effects of HOXB4 on nonhuman primate short and long-term repopulating cells

MDCT urography shows potential for detecting bladder cancer without surgery

Cancer Research eBook

Revolutionizing Life Science: An Interview with SCIEX on ASMS, the SCIEX 7500+ System, and AI-Driven Quantitation

From Discovery Biology to ELRIG Chair

Breathing New Life into Diagnostics: Plasmion's SICRIT Technology

Chemotherapy News and Research

Latest Chemotherapy News and Research

Cancer Research eBook

Revolutionizing Life Science: An Interview with SCIEX on ASMS, the SCIEX 7500+ System, and AI-Driven Quantitation

From Discovery Biology to ELRIG Chair

Breathing New Life into Diagnostics: Plasmion's SICRIT Technology

Newsletters you may be interested in